Main Article Content
Abstract
Background: Third-degree burns cause extensive tissue damage, prolonged inflammation, and delayed wound healing. Increased expression of pro-inflammatory cytokines, particularly interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), may worsen tissue injury and impair repair. Modulating these mediators may improve healing outcomes in third-degree burns.
Objective: To evaluate the effect of hypoxia-conditioned mesenchymal stem cell exosomes (HC-MSC-Exo) on IL-1β and TNF-α mRNA expression in a model of third-degree burns.
Methods: An experimental post-test-only for control s study was conducted using thirty male Wistar rats (6–8 weeks; 200–250 g). Animals were randomly divided into five grups study: healthy control, burn + NaCl, burn + silver sulfadiazine, burn + HC-MSC-Exo 100 μg/mL, and burn + HC-MSC-Exo 200 μg/mL. Third-degree burns were induced using a 2 × 2 cm2 heated copper plate. The HC-MSC-Exo was administered subcutaneously around the wound. Wound evaluation was performed on days 0, 3, and 7. On day 7, burn tissue was collected for analysis of IL-1β and TNF-α mRNA expression.
Results: Untreated burn wounds showed higher IL-1β and TNF-α mRNA expression than healthy controls. HC-MSC-Exo administration reduces the expression of both inflammatory markers, with the 200 μg/mL group showing the lowest levels. Macroscopic wound healing also improves in the HC-MSC-Exo, particularly in the 200 μg/mL , as indicated by smaller wound area and less visible necrotic tissue.
Conclusion: HC-MSC-Exo reduces IL-1β and TNF-α mRNA expression and improves macroscopic wound healing in a model of third-degree burns, suggesting that HC-MSC-Exo may be a promising therapeutic approach for burn injury.
Keywords
Article Details
Copyright (c) 2026 Christiani Natalia Soemitha, Eko Setiawan, Chodidjah Chodidjah
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:
- Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.